Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mette Julsgaard

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Alimentary Pharmacology & Therapeutics|November 7, 2019
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE studyAnnick Moens, C Janneke van der Woude, Mette Julsgaard, et al.
United European Gastroenterology Journal|August 19, 2025
Patient and First-Degree Relatives Perceptions About Prediction and Prevention of Inflammatory Bowel Disease-A Multinational SurveyAna Catarina Bravo, Sara Godt Christensen, Mette Julsgaard, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)María José García, Sabino Riestra, Aurelien Amiot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 26, 2024
Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During PregnancyMette Julsgaard, Jantien W Wieringa, Simon M D Baunwall, et al.
Journal of Crohn'S & Colitis|April 5, 2022
Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study]María Chaparro, Lumír Kunovský, Mariam Aguas, et al.
United European Gastroenterology Journal|October 14, 2025
International Survey of Gastroenterologists on Managing Inflammatory Bowel Disease During Pregnancy and Lactation: Current State and the Necessity for ImprovementsMaría José Casanova, Javier P Gisbert, Aurelien Amiot, et al.
Journal of Crohn'S & Colitis|November 29, 2023
A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus ProcessLiselotte Fierens, Nicholas Carney, Gottfried Novacek, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2025
Real-world effectiveness of advanced therapies in microscopic colitisBram Verstockt, Thibault Taelman, Shahida Din, et al.
Journal of Crohn'S & Colitis|November 3, 2025
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment classTommaso Innocenti, Jurij Hanžel, Marie Truyens, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|November 7, 2019
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE studyAnnick Moens, C Janneke van der Woude, Mette Julsgaard, et al.
United European Gastroenterology Journal|August 19, 2025
Patient and First-Degree Relatives Perceptions About Prediction and Prevention of Inflammatory Bowel Disease-A Multinational SurveyAna Catarina Bravo, Sara Godt Christensen, Mette Julsgaard, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2024
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)María José García, Sabino Riestra, Aurelien Amiot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 26, 2024
Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During PregnancyMette Julsgaard, Jantien W Wieringa, Simon M D Baunwall, et al.
Journal of Crohn'S & Colitis|April 5, 2022
Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study]María Chaparro, Lumír Kunovský, Mariam Aguas, et al.
United European Gastroenterology Journal|October 14, 2025
International Survey of Gastroenterologists on Managing Inflammatory Bowel Disease During Pregnancy and Lactation: Current State and the Necessity for ImprovementsMaría José Casanova, Javier P Gisbert, Aurelien Amiot, et al.
Journal of Crohn'S & Colitis|November 29, 2023
A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus ProcessLiselotte Fierens, Nicholas Carney, Gottfried Novacek, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2025
Real-world effectiveness of advanced therapies in microscopic colitisBram Verstockt, Thibault Taelman, Shahida Din, et al.
Journal of Crohn'S & Colitis|November 3, 2025
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment classTommaso Innocenti, Jurij Hanžel, Marie Truyens, et al.
Pageof 6